Effect of Omalizumab in Patients With Severe Persistent Non-atopic Uncontrolled Asthma
Clinical trial NCT01007149 · COMPLETED
Trial details
- NCT number
- NCT01007149
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-09-01
- Primary completion
- 2011-02-01
- Enrollment
- 79
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.